New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 18, 2014
09:10 EDTGNCGNC Holdings announces Corporate Controller Andrew Drexler to resign
Drexler will resign from the company effective February 28 to serve as CFO of another large retail company.
News For GNC From The Last 14 Days
Check below for free stories on GNC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
10:00 EDTGNCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AB InBev (BUD) upgraded to Hold from Sell at Societe Generale... Baker Hughes (BHI) upgraded to Outperform from Sector Perform at Howard Weil... Bank of the Ozarks (OZRK) upgraded to Buy from Hold at BB&T... Bill Barrett (BBG) upgraded to Buy from Neutral at Mizuho... Cepheid (CPHD) upgraded to Buy from Hold at Cantor... Cigna (CI) upgraded to Positive from Neutral at Susquehanna... Extra Space Storage (EXR) upgraded to Buy from Hold at Jefferies... GNC Holdings (GNC) upgraded to Outperform from Neutral at Wedbush... MB Financial (MBFI) upgraded at DA Davidson... Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale... Radian Group (RDN) upgraded to Buy from Neutral at Compass Point... Skullcandy (SKUL) assumed with a Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray.
09:00 EDTGNCGNC Holdings estimates cut 'well below' consensus at William Blair
William Blair lowered its estimates for GNC Holdings "well below" the current consensus after taking down its 2014 earnings estimate by 5c to $2.65 and 2015 estimate by 10c to $2.90. The firm finds it "tough to identify" any improvement in operating trends during Q3, and feels the departure of four key executives in the last three months suggests "deeper fundamental issues" for the company. William Blair lists large overlap in product assortment with Amazon (AMZN) and buy-one-get-one promotional activity continuing in Q3 as reasons for concern. The firm reiterates an Underperform rating on GNC and notes the stock is up nearly 20% since the Q2 release.
07:01 EDTGNCGNC Holdings upgraded to Outperform from Neutral at Wedbush
Wedbush upgraded GNC Holdings to Outperform following store checks that indicate stabilizing trends with a reduction in promotional activity. The firm believes GNC Holdings' reduced guidance in July is realistic and that re-franchising company-owned stores will be viewed positively by investors. Price target raised to $46 from $34.
September 12, 2014
10:35 EDTGNCVitamin Shoppe may consider selling itself, analyst says
Vitamin retailer Vitamin Shoppe (VSI) could be considering selling itself after its 52 year old CEO announced that he would retire, Sterne Agee wrote in a note to investors today. WHAT'S NEW: After Vitamin Shoppe announced on September 10 that its CEO Tony Truesdale would retire effective June 2015, Sterne Agee analyst Charles Grom wrote that the news was surprising, in light of Truesdale's age and several initiatives recently carried out by the company. Given Truesdale's departure and the lack of available high-caliber retail management talent, along with Vitamin Shoppe's recent move into manufacturing via its acquisition of nutritional product maker Nutri-Force, Vitamin Shoppe's board may be considering selling the company, the analyst believes. Vitamin Shoppe could be weighing selling itself to competitor GNC (GNC) or a private equity firm, Grom wrote. He kept a $53 price target and Buy rating on Vitamin Shoppe. WHAT'S NOTABLE: In a note to investors on August 11, Credit Suisse predicted that GNC and Vitamin Shoppe could combine. The merger would create $135M of synergies and grow the combined entity's earnings before interest taxes depreciation and amortization by nearly 20%, the analyst predicted. Additionally, the companies have a great deal of store overlap, and the new CEO of GNC is a former president of Vitamin Shoppe, increasing the chances that a merger would be successful, Credit Suisse stated. PRICE ACTION: In mid-morning trading, Vitamin Shoppe lost 1% to $43, while GNC advanced 1% to $39.50.
09:20 EDTGNCVitamin Shoppe may be weighing sale of company, says Sterne Agee
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use